ARTL Stock Analysis: Buy, Sell, or Hold?
ARTL - Artelo Biosciences, Inc. Common Stock
$1.53
-0.10 (-6.13%)
▼
5d:
-15.93%
30d:
+20.47%
90d:
-50.65%
WAIT
LOW Confidence
Last Updated: February 3, 2026
Earnings: Mar 02, 2026
25d
Get Alerted When ARTL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ARTL is down 15.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ARTL is down 15.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ARTL is currently trading at $1.53, which is considered fair relative to its 30-day fair value range of $1.35 to $1.75.
Technical Outlook: Technically, ARTL is in a strong downtrend. The price is currently testing key support at $1.50. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.1% recently.
Market Sentiment: ARTL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $18.00 (+1076.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ARTL is in a strong downtrend. The price is currently testing key support at $1.50. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.1% recently.
Market Sentiment: ARTL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $18.00 (+1076.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.35 -
$1.75
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.1%)
- BULLISH: Trading 1076.5% below Wall St target ($18.00)
- WARNING: Recommendation downgraded due to -15.9% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.35 -
$1.75
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$1.50
Resistance Level
$1.88
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.47
Wall Street Target
$18.00
(+1076.5%)
Last updated: February 04, 2026 1:46 AM ET
Data refreshes hourly during market hours. Next update: 2:46 AM
Data refreshes hourly during market hours. Next update: 2:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARTL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 61 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 63 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 54 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 56 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 59 HOLD |
